Regarding clinical factors, previous studies have demonstrated that characteristics such as tumor volume, tumor margin, and tumor-brain interface correlate with Ki-67 expression in meningioma (33), which is consistent with our findings. This evidence concerns the gene MKI67 and meningioma.